Page last updated: 2024-10-21

tacrine and Tauopathies

tacrine has been researched along with Tauopathies in 2 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Pietro, O1
Pérez-Areales, FJ1
Juárez-Jiménez, J1
Espargaró, A1
Clos, MV1
Pérez, B1
Lavilla, R1
Sabaté, R1
Luque, FJ1
Muñoz-Torrero, D1
Ballard, CG1
Chalmers, KA1
Todd, C1
McKeith, IG1
O'Brien, JT1
Wilcock, G1
Love, S1
Perry, EK1

Other Studies

2 other studies available for tacrine and Tauopathies

ArticleYear
Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Cholinesterases; Dose-Response

2014
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
    Neurology, 2007, May-15, Volume: 68, Issue:20

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Autopsy; Cerebral Cortex; Cholinesterase Inhibitors;

2007